DSM reported that despite seeing a 4% rise in sales to €168m in Q3, its operating profit was -€6m, below that from the same period in 2009. The company said this was the result of no change in the challenging business dynamics that the entire pharmaceutical industry is facing.
DSM
Wednesday 3 November 2010
DSM pharma results negative
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment